Bioatla Total Cashflows From Investing Activities from 2010 to 2024

BCAB Stock  USD 1.68  0.04  2.44%   
Bioatla's Total Cashflows From Investing Activities is increasing over the years with slightly volatile fluctuation. Total Cashflows From Investing Activities is expected to dwindle to about -320 K. Total Cashflows From Investing Activities is the net amount of cash used in or generated from a company's investment activities, such as purchasing or selling assets, during a reporting period. View All Fundamentals
 
Total Cashflows From Investing Activities  
First Reported
2010-12-31
Previous Quarter
-304.8 K
Current Value
-320 K
Quarterly Volatility
338 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Bioatla financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bioatla's main balance sheet or income statement drivers, such as Net Interest Income of 6 M, Interest Income of 6 M or Depreciation And Amortization of 1.2 M, as well as many indicators such as Price To Sales Ratio of 2.6 K, Dividend Yield of 0.0 or PTB Ratio of 1.75. Bioatla financial statements analysis is a perfect complement when working with Bioatla Valuation or Volatility modules.
  
Check out the analysis of Bioatla Correlation against competitors.
For information on how to trade Bioatla Stock refer to our How to Trade Bioatla Stock guide.

Latest Bioatla's Total Cashflows From Investing Activities Growth Pattern

Below is the plot of the Total Cashflows From Investing Activities of Bioatla over the last few years. It is the net amount of cash used in or generated from a company's investment activities, such as purchasing or selling assets, during a reporting period. Bioatla's Total Cashflows From Investing Activities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bioatla's overall financial position and show how it may be relating to other accounts over time.
Total Cashflows From Investing Activities10 Years Trend
Slightly volatile
   Total Cashflows From Investing Activities   
       Timeline  

Bioatla Total Cashflows From Investing Activities Regression Statistics

Arithmetic Mean(853,649)
Coefficient Of Variation(39.59)
Mean Deviation257,981
Median(988,000)
Standard Deviation337,955
Sample Variance114.2B
Range1.2M
R-Value0.60
Mean Square Error78B
R-Squared0.37
Significance0.02
Slope45,709
Total Sum of Squares1.6T

Bioatla Total Cashflows From Investing Activities History

2024-320 K
2023-304.8 K
2022-265 K
2021-924 K
2020-590 K
2019-1.5 M

About Bioatla Financial Statements

Bioatla stakeholders use historical fundamental indicators, such as Bioatla's Total Cashflows From Investing Activities, to determine how well the company is positioned to perform in the future. Although Bioatla investors may analyze each financial statement separately, they are all interrelated. For example, changes in Bioatla's assets and liabilities are reflected in the revenues and expenses on Bioatla's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Bioatla. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Cashflows From Investing Activities-304.8 K-320 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Bioatla offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bioatla's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bioatla Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bioatla Stock:
Check out the analysis of Bioatla Correlation against competitors.
For information on how to trade Bioatla Stock refer to our How to Trade Bioatla Stock guide.
You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bioatla. If investors know Bioatla will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bioatla listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.70)
Revenue Per Share
0.228
Quarterly Revenue Growth
0.316
Return On Assets
(0.50)
Return On Equity
(1.39)
The market value of Bioatla is measured differently than its book value, which is the value of Bioatla that is recorded on the company's balance sheet. Investors also form their own opinion of Bioatla's value that differs from its market value or its book value, called intrinsic value, which is Bioatla's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bioatla's market value can be influenced by many factors that don't directly affect Bioatla's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bioatla's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bioatla is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bioatla's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.